TOFUTTI BRANDS INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that TOFUTTI BRANDS INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 30, 2017 | $14.11M | Mar 29, 2018 |
| FY2017 | Dec 31, 2016 | $14.47M | Mar 29, 2018 |
| FY2016 | Jan 2, 2016 | $13.76M | Mar 31, 2017 |
| FY2015 | Dec 27, 2014 | $14.35M | Apr 1, 2016 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 27, 2025 | $7.78M | Apr 13, 2026 |
| FY2025 | Dec 28, 2024 | $8.82M | Apr 13, 2026 |
| FY2024 | Dec 30, 2023 | $10.07M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $12.83M | Apr 3, 2024 |
| FY2022 | Jan 1, 2022 | $12.59M | Mar 31, 2023 |
| FY2022 | Jan 2, 2021 | $13.82M | Apr 1, 2022 |
| FY2020 | Dec 28, 2019 | $13.13M | Apr 19, 2021 |
| FY2019 | Dec 29, 2018 | $13.07M | Apr 21, 2020 |
| FY2018 | Dec 30, 2017 | $14.11M | Mar 29, 2019 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2013 | Dec 28, 2013 | $14.69M | Mar 28, 2014 |
| FY2013 | Dec 29, 2012 | $14.34M | Mar 28, 2014 |
| FY2011 | Dec 31, 2011 | $15.93M | Apr 5, 2012 |
| FY2011 | Jan 1, 2011 | $17.71M | Apr 5, 2012 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 27, 2025 | $2.05M | Apr 13, 2026 |
| FY2025 | Dec 28, 2024 | $2.25M | Apr 13, 2026 |
| FY2024 | Dec 30, 2023 | $2.80M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $2.34M | Apr 3, 2024 |
| FY2022 | Jan 1, 2022 | $3.34M | Mar 31, 2023 |
| FY2022 | Jan 2, 2021 | $4.25M | Apr 1, 2022 |
| FY2020 | Dec 28, 2019 | $4.04M | Apr 19, 2021 |
| FY2019 | Dec 29, 2018 | $4.10M | Apr 21, 2020 |
| FY2018 | Dec 30, 2017 | $4.74M | Mar 29, 2019 |
| FY2017 | Dec 31, 2016 | $4.59M | Mar 29, 2018 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 27, 2025 | ($778.0K) | Apr 13, 2026 |
| FY2025 | Dec 28, 2024 | ($860.0K) | Apr 13, 2026 |
| FY2024 | Dec 30, 2023 | ($366.0K) | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | ($525.0K) | Apr 3, 2024 |
| FY2022 | Jan 1, 2022 | $143.0K | Mar 31, 2023 |
| FY2022 | Jan 2, 2021 | $596.0K | Apr 1, 2022 |
| FY2020 | Dec 28, 2019 | $78.0K | Apr 19, 2021 |
| FY2019 | Dec 29, 2018 | $507.0K | Apr 21, 2020 |
| FY2018 | Dec 30, 2017 | $704.0K | Mar 29, 2019 |
| FY2017 | Dec 31, 2016 | $421.0K | Mar 29, 2018 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 27, 2025 | ($773.0K) | Apr 13, 2026 |
| FY2025 | Dec 28, 2024 | ($607.0K) | Apr 13, 2026 |
| FY2024 | Dec 30, 2023 | ($238.0K) | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | ($916.0K) | Apr 3, 2024 |
| FY2022 | Jan 1, 2022 | $242.0K | Mar 31, 2023 |
| FY2022 | Jan 2, 2021 | $876.0K | Apr 1, 2022 |
| FY2020 | Dec 28, 2019 | $108.0K | Apr 19, 2021 |
| FY2019 | Dec 29, 2018 | $372.0K | Apr 21, 2020 |
| FY2018 | Dec 30, 2017 | $750.0K | Mar 29, 2019 |
| FY2017 | Dec 31, 2016 | $475.0K | Mar 29, 2018 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 27, 2025 | $156.0K | Apr 13, 2026 |
| FY2025 | Dec 28, 2024 | $132.0K | Apr 13, 2026 |
| FY2024 | Dec 30, 2023 | $166.0K | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $143.0K | Apr 3, 2024 |
| FY2022 | Jan 1, 2022 | $124.0K | Mar 31, 2023 |
| FY2022 | Jan 2, 2021 | $240.0K | Apr 1, 2022 |
| FY2020 | Dec 28, 2019 | $324.0K | Apr 19, 2021 |
| FY2019 | Dec 29, 2018 | $410.0K | Apr 21, 2020 |
| FY2018 | Dec 30, 2017 | $393.0K | Mar 29, 2019 |
| FY2017 | Dec 31, 2016 | $426.0K | Mar 29, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 27, 2025 | ($98.0K) | Apr 13, 2026 |
| FY2025 | Dec 28, 2024 | ($358.0K) | Apr 13, 2026 |
| FY2024 | Dec 30, 2023 | ($225.0K) | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | ($616.0K) | Apr 3, 2024 |
| FY2022 | Jan 1, 2022 | $689.0K | Mar 31, 2023 |
| FY2022 | Jan 2, 2021 | $780.0K | Apr 1, 2022 |
| FY2020 | Dec 28, 2019 | ($15.0K) | Apr 19, 2021 |
| FY2019 | Dec 29, 2018 | ($725.0K) | Apr 21, 2020 |
| FY2018 | Dec 30, 2017 | $1.29M | Mar 29, 2019 |
| FY2017 | Dec 31, 2016 | ($418.0K) | Mar 29, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Dec 28, 2019 | $29.0K | Apr 19, 2021 |
| FY2019 | Dec 29, 2018 | $121.0K | Apr 21, 2020 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 27, 2025 | $3.38M | Apr 13, 2026 |
| FY2025 | Dec 28, 2024 | $3.82M | Apr 13, 2026 |
| FY2024 | Dec 30, 2023 | $4.62M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $5.52M | Apr 3, 2024 |
| FY2022 | Jan 1, 2022 | $5.34M | Mar 31, 2023 |
| FY2022 | Jan 2, 2021 | $6.08M | Apr 1, 2022 |
| FY2020 | Dec 28, 2019 | $5.03M | Apr 19, 2021 |
| FY2019 | Dec 29, 2018 | $4.89M | Apr 21, 2020 |
| FY2018 | Dec 30, 2017 | $4.85M | Mar 29, 2019 |
| FY2017 | Dec 31, 2016 | $4.52M | Mar 29, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 27, 2025 | $1.18M | Apr 13, 2026 |
| FY2025 | Dec 28, 2024 | $837.0K | Apr 13, 2026 |
| FY2024 | Dec 30, 2023 | $823.0K | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $1.42M | Apr 3, 2024 |
| FY2022 | Jan 1, 2022 | $775.0K | Mar 31, 2023 |
| FY2022 | Jan 2, 2021 | $1.66M | Apr 1, 2022 |
| FY2020 | Dec 28, 2019 | $1.20M | Apr 19, 2021 |
| FY2019 | Dec 29, 2018 | $1.14M | Apr 21, 2020 |
| FY2018 | Dec 30, 2017 | $1.61M | Mar 29, 2019 |
| FY2017 | Dec 31, 2016 | $2.05M | Mar 29, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 27, 2025 | $2.21M | Apr 13, 2026 |
| FY2025 | Dec 28, 2024 | $2.99M | Apr 13, 2026 |
| FY2025 | Dec 30, 2023 | $3.79M | Apr 13, 2026 |
| FY2024 | Dec 31, 2022 | $4.10M | Mar 31, 2025 |
| FY2023 | Jan 1, 2022 | $4.57M | Apr 3, 2024 |
| FY2022 | Jan 2, 2021 | $4.42M | Mar 31, 2023 |
| FY2022 | Dec 28, 2019 | $3.83M | Apr 1, 2022 |
| FY2020 | Dec 29, 2018 | $3.75M | Apr 19, 2021 |
| FY2019 | Dec 30, 2017 | $3.24M | Apr 21, 2020 |
| FY2018 | Dec 31, 2016 | $2.47M | Mar 29, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 27, 2025 | $1.78M | Apr 13, 2026 |
| FY2025 | Dec 28, 2024 | $2.56M | Apr 13, 2026 |
| FY2024 | Dec 30, 2023 | $3.42M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $3.78M | Apr 3, 2024 |
| FY2022 | Jan 1, 2022 | $4.31M | Mar 31, 2023 |
| FY2022 | Jan 2, 2021 | $4.17M | Apr 1, 2022 |
| FY2020 | Dec 28, 2019 | $3.57M | Apr 19, 2021 |
| FY2019 | Dec 29, 2018 | $3.49M | Apr 21, 2020 |
| FY2018 | Dec 30, 2017 | $2.98M | Mar 29, 2019 |
| FY2017 | Dec 31, 2016 | $2.28M | Mar 29, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2019 | Dec 28, 2019 | $514.0K | Apr 21, 2020 |
| FY2019 | Dec 29, 2018 | $558.0K | Apr 21, 2020 |
| FY2018 | Dec 30, 2017 | $1.41M | Mar 29, 2019 |
| FY2018 | Dec 31, 2016 | $132.0K | Mar 29, 2019 |
| FY2017 | Jan 2, 2016 | $55.0K | Mar 29, 2018 |
| FY2016 | Dec 27, 2014 | $341.0K | Mar 31, 2017 |
| FY2015 | Dec 28, 2013 | $214.0K | Apr 1, 2016 |
| FY2014 | Dec 29, 2012 | $471.0K | Mar 27, 2015 |
| FY2013 | Dec 31, 2011 | $1.59M | Mar 28, 2014 |
| FY2011 | Jan 1, 2011 | $2.53M | Apr 5, 2012 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 27, 2025 | 0 | Apr 13, 2026 |
| FY2025 | Dec 28, 2024 | 0 | Apr 13, 2026 |
| FY2024 | Dec 30, 2023 | 0 | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Apr 3, 2024 |
| FY2022 | Jan 1, 2022 | 0 | Mar 31, 2023 |
| FY2022 | Jan 2, 2021 | 0 | Apr 1, 2022 |
| FY2020 | Dec 28, 2019 | 0 | Apr 19, 2021 |
| FY2013 | Dec 28, 2013 | 0 | Mar 28, 2014 |
| FY2013 | Dec 29, 2012 | 0 | Mar 28, 2014 |
| FY2011 | Dec 31, 2011 | 0 | Apr 5, 2012 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 27, 2025 | 0 | Apr 13, 2026 |
| FY2025 | Dec 28, 2024 | 0 | Apr 13, 2026 |
| FY2024 | Dec 30, 2023 | 0 | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Apr 3, 2024 |
| FY2022 | Jan 1, 2022 | 0 | Mar 31, 2023 |
| FY2022 | Jan 2, 2021 | 0 | Apr 1, 2022 |
| FY2020 | Dec 28, 2019 | 0 | Apr 19, 2021 |
| FY2013 | Dec 28, 2013 | 0 | Mar 28, 2014 |
| FY2013 | Dec 29, 2012 | 0 | Mar 28, 2014 |
| FY2011 | Dec 31, 2011 | 0 | Apr 5, 2012 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 27, 2025 | 5.15M | Apr 13, 2026 |
| FY2025 | Dec 28, 2024 | 5.15M | Apr 13, 2026 |
| FY2024 | Dec 30, 2023 | 5.15M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | 5.15M | Apr 3, 2024 |
| FY2022 | Jan 1, 2022 | 5.15M | Mar 31, 2023 |
| FY2022 | Jan 2, 2021 | 5.15M | Apr 1, 2022 |
| FY2020 | Dec 28, 2019 | 5.15M | Apr 19, 2021 |
| FY2019 | Dec 29, 2018 | 5.15M | Apr 21, 2020 |
| FY2018 | Dec 30, 2017 | 5.15M | Mar 29, 2019 |
| FY2017 | Dec 31, 2016 | 5.15M | Mar 29, 2018 |